Design of antimalarial drugs with immunoprotective activity: the Borrelidin model

dc.contributor.authorAzcárate, I. G.spa
dc.contributor.authorMarín-García, Patriciaspa
dc.contributor.authorCamacho, N.spa
dc.contributor.authorPuyet, Antoniospa
dc.contributor.authorDíez, Amaliaspa
dc.contributor.authorRibas de Pouplana, L.spa
dc.contributor.authorBautista, José M.spa
dc.date.accessioned2013-11-27T17:26:50Z
dc.date.available2013-11-27T17:26:50Z
dc.date.issued2011spa
dc.description.impact2.795 JCR (2011) Q1, 32/158 Public, environmental & occupational health, 3/21 Tropical medicinespa
dc.identifier.citationAzcárate, I. G., Marín-García, P., Camacho, N., Puyet, A., Díez, A., Ribas-Pouplana, L., & Bautista, J. M. (2011). Design of antimalarial drugs with immunoprotective activity: the Borrelidin model. Tropical Medicine & International Health, 16(s-1), 141.spa
dc.identifier.doi10.1111/j.1365-3156.2011.02861.xspa
dc.identifier.issn13602276spa
dc.identifier.urihttp://hdl.handle.net/11268/1092
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessen
dc.subject.unescoMalariaspa
dc.titleDesign of antimalarial drugs with immunoprotective activity: the Borrelidin modelspa
dc.typejournal articlespa
dspace.entity.typePublication

Files